Screener
Indivior Pharmaceuticals, Inc. INDV Interest Expense
Interest Expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s interest expense?
- Indivior Pharmaceuticals, Inc. (INDV) reported interest expense of $7M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s interest expense changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s interest expense decreased by 41.7% year-over-year, from $12M to $7M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s interest expense?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s interest expense has grown at a 18.6% compound annual growth rate (CAGR), from $27M to $45M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Indivior Pharmaceuticals, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude